E-Book Resources
| Title | Link |
| Community Health Worker Support and Clinician Education for Tobacco Cessation in Adults with Serious Mental Illness: A Pragmatic, Cluster-Randomized Clinical Trial | Open PDF |
| The Impact of Medicaid Health Homes on Patients with Diabetes | Open PDF |
| Facilitated Telemedicine for Underserved Populations: Management of Chronic Hepatitis C Virus Infection. The TEAM-C Study | Open PDF |
| Evaluating the Comparative Effectiveness of Telemedicine in Primary Care: Learning From the COVID-19 Pandemic | Open PDF |
| Strategies To Assist with Management of Pain (STAMP) Study | Open PDF |
| Comparing Ways to Help Veterans Manage Chronic Pain—The VOICE Study | Open PDF |
| Appraisal of joint tobacco and alcohol tax interventions for harm reduction in the UK: the SYNTAX integrated evidence synthesis project | Open PDF |
| Fezolinetant for treating moderate to severe vasomotor symptoms associated with menopause | Open PDF |
| Study into the Reversal of Septic Shock with Beta Blockade (Landiolol): the STRESS-L randomised trial | Open PDF |
| 4% w/w Fluorouracil Sodium Cream (Tolak): Therapeutic area: Actinic keratosis lesions: Reimbursement Review | Open PDF |
| Dextrose Prolotherapy for Musculoskeletal Conditions: Health Technologies | Open PDF |
| Toripalimab (Loqtorzi): Therapeutic area: Recurrent or metastatic nasopharyngeal carcinoma: Reimbursement Review | Open PDF |
| Paramedic analgesia comparing ketamine and morphine in trauma. A synopsis of the PACKMaN double-blind RCT | Open PDF |
| Cancer Care in the Post-COVID World: A UK and European Perspective on Learning from the Pandemic | Open PDF |
| Integrated therapist and online cognitive behavioural therapy for depression in primary care: the INTERACT research programme, including the INTERACT RCT | Open PDF |
| Finerenone (Kerendia): Therapeutic area: Heart failure: Reimbursement Review | Open PDF |
| Bimekizumab (Bimzelx): Indication: For the treatment of adult patients with moderate to severe hidradenitis suppurativa with an inadequate response to conventional systemic therapy: Reimbursement Recommendation | Open PDF |
| Tezepelumab (Tezspire): Indication: As an add-on maintenance treatment with intranasal corticosteroids in adult patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) inadequately controlled by systemic corticosteroids and/or surgery: Reimbursement Recommendation | Open PDF |
| Disease-Modifying Therapies for Metabolic Dysfunction–Associated Steatohepatitis: Health Systems | Open PDF |
| Comparing Primary Care Team-Based with Individual Clinician-Focused Implementation of Advance Care Planning: A Cluster-Randomized Trial in Practice-Based Research Networks | Open PDF |
| A Natural Language Processing Tool for Extracting Medication Adherence Information From Electronic Health Records | Open PDF |
| Iptacopan (Fabhalta): Indication: For the treatment of adult patients with C3 glomerulopathy to reduce proteinuria: Reimbursement Recommendation | Open PDF |
| Roflumilast (Zoryve): Indication: For the topical treatment of plaque psoriasis of the scalp and body in patients 12 years of age and older: Reimbursement Recommendation | Open PDF |
| Roflumilast (Zoryve): Therapeutic area: Atopic dermatitis: Reimbursement Review | Open PDF |
| Developing New Methods that Estimate if Treatment Reduces the Risk of Death in Observational Studies | Open PDF |
| Optimising antibiotic ‘review and revise’ in acute/general medical inpatients: the Antibiotic Review Kit in Hospitals (ARK-Hospital) research programme including a stepped-wedge cluster-randomised trial | Open PDF |
| Effect of High-Deductible Health Plans on Healthcare Use and Out-of-Pocket Costs for People with Bipolar Disorder | Open PDF |
| Effects of e-cigarettes vs usual care for smoking cessation when offered at homeless centres: the SCeTCH cRCT synopsis | Open PDF |
| Penicillin allergy assessment pathway to improve antibiotic use: the ALABAMA intervention development, RCT, process and cost-effectiveness evaluation | Open PDF |
| Improving medicines use in people with polypharmacy in primary care: a synopsis from the IMPPP cluster-RCT with pilot-feasibility study | Open PDF |
| MOBILITY: Improving Patient-Centered Outcomes among Overweight and Obese Youth with Bipolar Spectrum Disorders Treated with Second-Generation Antipsychotics | Open PDF |
| Comparing Two Ways to Identify What’s Important to Patients in Research | Open PDF |
| Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over | Open PDF |
| Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial | Open PDF |
| Comparing Acupuncture and Massage to Treat Pain in Patients with Advanced Cancer—The IMPACT Study | Open PDF |
| Givinostat for treating Duchenne muscular dystrophy in people 6 years and over | Open PDF |
| Testing a Program to Help Monitor Chronic Hepatitis B among Asian-American Patients | Open PDF |
| Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluation | Open PDF |
| Evaluating Hormone Treatments for Women at Increased Risk for Preterm Birth—EPPPIC | Open PDF |
| Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancer | Open PDF |
| WHO guidelines for the clinical management of filovirus disease | Open PDF |
| Lived Experience of Household Overcrowding Measure (LE-HOMe): A mixed-methods feasibility study to measure household overcrowding affecting family wellbeing, informed by lived experience | Open PDF |
| U.S. Surgeon General’s Advisory: Surgeon General’s Warning on the Harms of Screen Use: An Advisory and Toolkit on how to protect children and adolescents | Open PDF |
| Appropriate Use of Antipsychotics in Long-Term Care: Environmental Scan: Drugs | Open PDF |
| Osilodrostat (Isturisa): Therapeutic area: Cushing’s disease: Reimbursement Review | Open PDF |
| Peer advocacy for people experiencing homelessness in London: a comprehensive synopsis of a mixed-method study including economic and process evaluation | Open PDF |
| Maralixibat (Livmarli): Indication: For the treatment of cholestatic pruritus in patients aged 12 months or older with progressive familial intrahepatic cholestasis: Reimbursement Recommendation | Open PDF |
| Beclomethasone, Glycopyrronium, and Formoterol (Trimbow): Indication: In adult patients who are not adequately treated by a combination of an ICS and a LABA or a combination of a LABA and a LAMA:: Reimbursement Recommendation | Open PDF |
| Risperidone Long-Acting Injection (Okedi): Therapeutic area: Schizophrenia, adults: Reimbursement Review | Open PDF |
| Seladelpar (Lyvdelzi): Therapeutic area: Primary biliary cholangitis: Reimbursement Review | Open PDF |